B-type natriuretic peptide assays for detecting heart failure in the elderly: Same value as those in the younger?

International Journal of Cardiology

Volumn 125, Issue 2, 2008, Pages 161-165

  Rutten, Frans H ^a   Hoes, Arno W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

B type natriuretic peptide; Diagnosis; Elderly; Heart failure

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ACUTE CORONARY SYNDROME; AGING; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DISEASE COURSE; DYSPNEA; ECHOCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HUMAN; KIDNEY CLEARANCE; LUNG ARTERY PRESSURE; LUNG EMBOLISM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; REVIEW; STABLE ANGINA PECTORIS;

AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL ASSAY; HEART FAILURE; HUMANS; NATRIURETIC PEPTIDE, BRAIN;

EID: 40849106446     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.10.006     Document Type: Review

References (24)

1. Mosterd A., Hoes A.W., de Bruyne M.C., et al. Prevalence of heart failure and left ventricular dysfunction in the general population; the Rotterdam Study. Eur Heart J 20 (1999) 447-455
2. Neubauer S. The failing heart-an engine out of fuel. N Engl J Med 356 (2007) 1140-1151
3. Mann D.L., and Bristow M.R. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 111 (2005) 2837-2849
4. Jessup M., and Brozena S. Heart failure. N Engl J Med 348 (2003) 2007-2018
5. Remes J., Miettinen H., Reunanen A., and Pyörälä K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 12 (1991) 315-321
6. Rutten F.H., Cramer M.J., Lammers J.W., Grobbee D.E., and Hoes A.W. Heart failure and chronic obstructive pulmonary disease: an ignored combination?. Eur J Heart Fail 8 (2006) 706-711
7. Rutten F.H., Grobbee D.E., and Hoes A.W. Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. Eur J Heart Fail 5 (2003) 337-344
8. Wheeldon N.M., MacDonald T.M., Flucker C.J., McKendrick A.D., McDevitt D.G., and Struthers A.D. Echocardiography in chronic heart failure in the community. Q J Med 86 (1993) 17-23
9. Cowie M.R., Struthers A.D., Wood D.A., et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350 (1997) 1349-1353
10. Fuat A., Hungin A.P., and Murphy J.J. Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. BMJ 326 (2003) 196
11. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
12. Nielsen L.S., Svanegaard J., Klitgaard A., and Egeblad H. N-terminal pro-brain natriuretic peptide for discriminating between cardiac and non-cardiac dyspnoea. Eur J Heart Fail 6 (2004) 63-70
13. Rutten F.H., Moons K.G., Cramer M.J., et al. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ 331 (2005) 1379
14. Cowie M.R., Jourdain P., Maisel A., et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 24 (2003) 1710-1718
15. Weber M., and Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart 92 (2006) 843-849
16. Galasko G.I., Lahiri A., Barnes S.C., Collinson P., and Senior R. What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease?. Eur Heart J 26 (2005) 2269-2276
17. Redfield M.M., Rodeheffer R.J., Jacobsen S.J., Mahoney D.W., Bailey K.R., and Burnett Jr. J.C. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 40 (2002) 976-982
18. Swedberg K., Cleland J., Dargie H., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
19. Rutten F.H., Cramer M.J., Zuithoff N.P., et al. Comparison of B-type natriuretic peptide assays for identifying heart failure in stable elderly patients with a clinical diagnosis of chronic obstructive pulmonary disease. Eur J Heart Fail 9 (2007) 651-659
20. Januzzi J.L., van Kimmenade R., Lainchbury J., et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the international collaborative of NT-proBNP Study. Eur Heart J 27 (2006) 330-337
21. Berdague P., Caffin P.Y., Barazer I., et al. Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients. Am Heart J 151 (2006) 690-698
22. Landray M.J., Lehman R., and Arnold I. Measuring brain natriuretic peptide in suspected left ventricular systolic dysfunction in general practice: cross-sectional study. BMJ 320 (2000) 985-986
23. Maisel A.S., Clopton P., Krishnaswamy P., et al. Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study. Am Heart J 147 (2004) 1078-1084
24. Hedberg P., Lonnberg I., Jonason T., Nilsson G., Pehrsson K., and Ringqvist I. Electrocardiogram and B-type natriuretic peptide as screening tools for left ventricular systolic dysfunction in a population-based sample of 75-year-old men and women. Am Heart J 148 (2004) 524-529